3-196472333-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152617.4(RNF168):​c.1202C>A​(p.Pro401Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.586 in 1,613,568 control chromosomes in the GnomAD database, including 287,146 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P401L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.50 ( 20697 hom., cov: 32)
Exomes 𝑓: 0.59 ( 266449 hom. )

Consequence

RNF168
NM_152617.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.44

Publications

39 publications found
Variant links:
Genes affected
RNF168 (HGNC:26661): (ring finger protein 168) This gene encodes an E3 ubiquitin ligase protein that contains a RING finger, a motif present in a variety of functionally distinct proteins and known to be involved in protein-DNA and protein-protein interactions. The protein is involved in DNA double-strand break (DSB) repair. Mutations in this gene result in Riddle syndrome. [provided by RefSeq, Sep 2011]
RNF168 Gene-Disease associations (from GenCC):
  • RIDDLE syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.641032E-5).
BP6
Variant 3-196472333-G-T is Benign according to our data. Variant chr3-196472333-G-T is described in ClinVar as Benign. ClinVar VariationId is 403381.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.609 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNF168NM_152617.4 linkc.1202C>A p.Pro401Gln missense_variant Exon 6 of 6 ENST00000318037.3 NP_689830.2 Q8IYW5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNF168ENST00000318037.3 linkc.1202C>A p.Pro401Gln missense_variant Exon 6 of 6 1 NM_152617.4 ENSP00000320898.3 Q8IYW5
RNF168ENST00000437070.1 linkn.*774C>A non_coding_transcript_exon_variant Exon 5 of 5 2 ENSP00000396712.1 F8WD60
RNF168ENST00000437070.1 linkn.*774C>A 3_prime_UTR_variant Exon 5 of 5 2 ENSP00000396712.1 F8WD60

Frequencies

GnomAD3 genomes
AF:
0.499
AC:
75789
AN:
151904
Hom.:
20700
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.301
Gnomad AMI
AF:
0.647
Gnomad AMR
AF:
0.441
Gnomad ASJ
AF:
0.617
Gnomad EAS
AF:
0.174
Gnomad SAS
AF:
0.597
Gnomad FIN
AF:
0.672
Gnomad MID
AF:
0.564
Gnomad NFE
AF:
0.614
Gnomad OTH
AF:
0.511
GnomAD2 exomes
AF:
0.536
AC:
134718
AN:
251322
AF XY:
0.554
show subpopulations
Gnomad AFR exome
AF:
0.290
Gnomad AMR exome
AF:
0.401
Gnomad ASJ exome
AF:
0.616
Gnomad EAS exome
AF:
0.165
Gnomad FIN exome
AF:
0.661
Gnomad NFE exome
AF:
0.618
Gnomad OTH exome
AF:
0.573
GnomAD4 exome
AF:
0.595
AC:
869575
AN:
1461548
Hom.:
266449
Cov.:
47
AF XY:
0.598
AC XY:
434639
AN XY:
727064
show subpopulations
African (AFR)
AF:
0.290
AC:
9711
AN:
33464
American (AMR)
AF:
0.406
AC:
18145
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.614
AC:
16054
AN:
26130
East Asian (EAS)
AF:
0.162
AC:
6443
AN:
39700
South Asian (SAS)
AF:
0.621
AC:
53572
AN:
86250
European-Finnish (FIN)
AF:
0.663
AC:
35408
AN:
53410
Middle Eastern (MID)
AF:
0.611
AC:
3522
AN:
5768
European-Non Finnish (NFE)
AF:
0.622
AC:
691719
AN:
1111728
Other (OTH)
AF:
0.580
AC:
35001
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
19255
38510
57766
77021
96276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18270
36540
54810
73080
91350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.499
AC:
75788
AN:
152020
Hom.:
20697
Cov.:
32
AF XY:
0.499
AC XY:
37046
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.301
AC:
12456
AN:
41448
American (AMR)
AF:
0.441
AC:
6733
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.617
AC:
2142
AN:
3470
East Asian (EAS)
AF:
0.174
AC:
898
AN:
5170
South Asian (SAS)
AF:
0.597
AC:
2878
AN:
4818
European-Finnish (FIN)
AF:
0.672
AC:
7107
AN:
10574
Middle Eastern (MID)
AF:
0.555
AC:
162
AN:
292
European-Non Finnish (NFE)
AF:
0.614
AC:
41748
AN:
67956
Other (OTH)
AF:
0.510
AC:
1075
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1827
3654
5482
7309
9136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.571
Hom.:
110727
Bravo
AF:
0.468
TwinsUK
AF:
0.619
AC:
2297
ALSPAC
AF:
0.624
AC:
2405
ESP6500AA
AF:
0.312
AC:
1373
ESP6500EA
AF:
0.623
AC:
5354
ExAC
AF:
0.540
AC:
65614
Asia WGS
AF:
0.397
AC:
1380
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

RIDDLE syndrome Benign:2
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
15
DANN
Benign
0.88
DEOGEN2
Benign
0.013
T
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.000036
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
2.4
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.059
Sift
Benign
0.058
T
Sift4G
Benign
0.25
T
Polyphen
0.80
P
Vest4
0.29
MPC
0.21
ClinPred
0.016
T
GERP RS
4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.044
gMVP
0.069
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3796129; hg19: chr3-196199204; COSMIC: COSV58836639; COSMIC: COSV58836639; API